Literature DB >> 17470514

Osteopontin is required for mechanical stress-dependent signals to bone marrow cells.

Muneaki Ishijima1, Kunikazu Tsuji, Susan R Rittling, Teruhito Yamashita, Hisashi Kurosawa, David T Denhardt, Akira Nifuji, Yoichi Ezura, Masaki Noda.   

Abstract

Mechanical stress to bone plays a crucial role in the maintenance of bone homeostasis. It causes the deformation of bone matrix and generates strain force, which could initiate the mechano-transduction pathway. The presence of osteopontin (OPN), which is one of the abundant proteins in bone matrix, is required for the effects of mechanical stress on bone, as we have reported that OPN-null (OPN-/-) mice showed resistance to unloading-induced bone loss. However, cellular mechanisms underlying the phenomenon have not been completely elucidated. To obtain further insight into the role of OPN in mediating mechanical stress effect on bone, we examined in vitro mineralization and osteoclast-like cell formation in bone marrow cells obtained from hind limb bones of OPN-/- mice after tail suspension. The levels of mineralized nodule formation of bone marrow cells derived from the femora subjected to unloading were decreased compared with that from loaded control in wild-type mice. However, these were not decreased in cells from OPN-/- mice after tail suspension compared with that from loaded OPN-/- mice. Moreover, while spreading of osteoclast-like cells derived from bone marrow cells of the femora subjected to unloading was enhanced compared with that from loaded control in wild-type mice, this enhancement of spreading of these cells derived from the femora subjected to unloading was not recognized compared with those from loaded control in OPN-/- mice. These data provided cellular bases for the effect of the OPN deficiency on in vitro reduced mineralized nodule formation by osteoblasts and on enhancement of osteoclast spreading in vitro induced by the absence of mechanical stress. These in vitro results correlate well with the resistance to unloading-induced bone loss in OPN-/- mice in vivo, suggesting that OPN has an important role in the effects of unloading-induced alterations of differentiation of bone marrow into osteoblasts and osteoclasts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17470514     DOI: 10.1677/joe.1.06704

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  17 in total

1.  The dual role of osteopontin in acetaminophen hepatotoxicity.

Authors:  Chun-yan He; Bei-bei Liang; Xiao-yu Fan; Lei Cao; Rui Chen; Ya-jun Guo; Jian Zhao
Journal:  Acta Pharmacol Sin       Date:  2012-06-25       Impact factor: 6.150

2.  The myokine irisin increases cortical bone mass.

Authors:  Graziana Colaianni; Concetta Cuscito; Teresa Mongelli; Paolo Pignataro; Cinzia Buccoliero; Peng Liu; Ping Lu; Loris Sartini; Mariasevera Di Comite; Giorgio Mori; Adriana Di Benedetto; Giacomina Brunetti; Tony Yuen; Li Sun; Janne E Reseland; Silvia Colucci; Maria I New; Mone Zaidi; Saverio Cinti; Maria Grano
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-15       Impact factor: 11.205

3.  Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation.

Authors:  Muneaki Ishijima; Nobuharu Suzuki; Kentaro Hozumi; Tomoya Matsunobu; Keisuke Kosaki; Haruka Kaneko; John R Hassell; Eri Arikawa-Hirasawa; Yoshihiko Yamada
Journal:  Matrix Biol       Date:  2012-03-07       Impact factor: 11.583

4.  Osteopontin regulates anabolic effect in human menopausal osteoporosis with intermittent parathyroid hormone treatment.

Authors:  T-I Chiang; I-C Chang; H-S Lee; H Lee; C-H Huang; Y-W Cheng
Journal:  Osteoporos Int       Date:  2010-08-24       Impact factor: 4.507

5.  Radon balneotherapy and physical activity for osteoporosis prevention: a randomized, placebo-controlled intervention study.

Authors:  Martina Winklmayr; Christian Kluge; Wolfgang Winklmayr; Helmut Küchenhoff; Martina Steiner; Markus Ritter; Arnulf Hartl
Journal:  Radiat Environ Biophys       Date:  2014-10-02       Impact factor: 1.925

6.  Increased serum osteopontin is a risk factor for osteoporosis in menopausal women.

Authors:  I-C Chang; T-I Chiang; K-T Yeh; H Lee; Y-W Cheng
Journal:  Osteoporos Int       Date:  2010-03-18       Impact factor: 4.507

7.  Dynamic fluid flow stimulation on cortical bone and alterations of the gene expressions of osteogenic growth factors and transcription factors in a rat functional disuse model.

Authors:  Minyi Hu; Yi-Xian Qin
Journal:  Arch Biochem Biophys       Date:  2014-01-30       Impact factor: 4.013

8.  Osteopontin is required for unloading-induced osteoclast recruitment and modulation of RANKL expression during tooth drift-associated bone remodeling, but not for super-eruption.

Authors:  Cameron G Walker; Smit Dangaria; Yoshihiro Ito; Xianghong Luan; Thomas G H Diekwisch
Journal:  Bone       Date:  2010-09-07       Impact factor: 4.398

Review 9.  The effect of five proteins on stem cells used for osteoblast differentiation and proliferation: a current review of the literature.

Authors:  P Chatakun; R Núñez-Toldrà; E J Díaz López; C Gil-Recio; E Martínez-Sarrà; F Hernández-Alfaro; E Ferrés-Padró; L Giner-Tarrida; M Atari
Journal:  Cell Mol Life Sci       Date:  2013-04-09       Impact factor: 9.261

10.  Biological characteristics of foam cell formation in smooth muscle cells derived from bone marrow stem cells.

Authors:  Pengke Yan; Chenglai Xia; Caiwen Duan; Shihuang Li; Zhengrong Mei
Journal:  Int J Biol Sci       Date:  2011-08-05       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.